116
Archived articleThis is an archived article from 2025 - please note that any content within the article may be out of date.

Daily Stock Market Report (Mon 28th July 2025) - SAG, STV, CCC, KOO, EMAN, CWK, DOTD, CWR, OCN/HAN

Good morning! I don't know about you, but I'm still trying to get accustomed to the FTSE having a "9" handle (that means having a 9 as its first digit!).

0a91949a-5323-4617-b70d-e80c0d441b65.png

Stockopedia provides this table of median ratios - I'm relieved to see that they aren't particularly stretched:

2b4451d1-e571-455e-b029-7194c4daa29d.png

12:45pm: wrapping it up there, thanks for all the comments and interaction! Graham

Spreadsheet accompanying this report: link (last updated: 30th June).


Companies Reporting

Name (Mkt Cap)RNSSummaryOur view (Author)

GSK (LON:GSK) (£56.8bn)

GSK Enters Hengrui Pharma collaboration agreements

Will co-develop 12 medicines across respiratory, immunology and inflammation/oncology.

Cranswick (LON:CWK) (£2.9bn)

First quarter trading statement

Rev +7.9% LFL w/ volume growth and outperformance of premium ranges.
Pet revenue also “well ahead” reflecting rollout of Pets at Home contract.
FY26 outlook in line. Updated forecasts from Shore Capital: FY26E EPS: 286.7p (prev. 280.8p)

AMBER/GREEN (Roland) [no section below]
Today’s update from this food producer seems strong to me and has prompted house broker Shore Capital to nudge its forecasts slightly higher. Cranswick doesn’t generate high margins, but it does deliver quite high returns on capital. I see this as being driven by good scale and strong management. I don’t see any reason for this to change in the near future. An independent investigation remains underway relating to alleged mistreatment of animals at one plant, but the company says it has already strengthened its processes. Investment is also underway to add capacity and improve efficiency. Notably, £14m of investment has been committed at the Lincoln pet site to support new business wins.
The StockRanks view Cranswick as a High Flyer, with strong Quality and Momentum scores. I’m inclined to agree and have left Graham’s moderately positive view from May unchanged today.

Computacenter (LON:CCC) (£2.4bn)

Trading Update

SP: unchanged
H1 rev growth in N.Am & UK, but softer in DE/FR due to lower public sector spending. H1 op profit to be “slightly ahead” of H1 24 figure of £81.1m. FY25 adj pre-tax profit to be “similar” to last year (FY24: £254m)

AMBER/GREEN (Roland holds) [no section below]
The market appears to have accepted today’s update as in line, although my first instinct at 7am was that it might be seen as slightly below. I think the saving grace here is continued “excellent” growth in North America, helping to offset weakness in Germany, which remains the group’s largest market by profit.
Looking ahead, I see the investment case being driven by continued growth in the US, driven by high volume deals with hyperscalers (large AI/data centre players). While the outlook is relatively flat right now, Computacenter has an excellent record of creating value for shareholders and remains under the effective voting control of its founders. On a P/E of 13 with net cash of £278m, I think the valuation looks undemanding and remain broadly positive.

Firstgroup (LON:FGP) (£1.3bn)

Acquisition

Acquired Leeds firm Tetley’s w/55 vehicles and strong contract portfolio. FY24 EBIT £1.4m.

Adriatic Metals (LON:ADT1) (£988m)

Quarterly Activities Report

Q2 +23% to 1.7Moz AgEq Tailings below exps. FY exps cut to 9.5-10.5Moz AgEq (prev. 12-13Moz).

Smarter Web (OFEX:SWC) (£592m)

Subscription Tranche Update - £19.7m Proceeds

6.1m new shares from 14m tranche sold at 325p per share from 7-25 July. Current SP 218p.

Ocean Wilsons Holdings (LON:OCN) (£413m)

Recommended All-Share Combination

OCN SP -14%
Combination with Hansa Investment (LON:HAN). OCN shareholders will receive 1.4925 new Hansa share units (each “unit” is one HAN share and two non-voting HANA shares) in exchange for every OCN share.

PINK (Graham) [no section below]
I covered this proposal briefly in June. The market doesn’t like the confirmation that the deal is progressing, but it’s due to some simple math: a Hansa share unit in the market today, as defined by the proposal, is worth about £12.30 according to my back-of-the-envelope calculations. So gravity must bring the OCN share price towards that level. However, as we discussed last time, the proposed merger will see the combined group enjoying lower management fee rates, a higher level of visibility due to increased size, and greater simplicity compared to their historic makeup. HAN shares are trading at 280p today but have a NAV of 408p as of 25 July, implying a discount to NAV that is still over 30%. I’m optimistic that the HAN/OCN combo might see this discount narrow.

Oxford BioMedica (LON:OXB) (£407m)

Half Year Trading Update

H1 rev £70-73m (+38-44% vs 1H24). £149m new orders in H1. FY25 exps unch; £160-170m rev.

Griffin Mining (LON:GFM) (£334m)

Receipt of $30m of Dividends from China

Rec’d $30.3m of dividends from its Chinese operating subsidiary re. FY24/5. Ex-China cash $53.7m.

Kenmare Resources (LON:KMR) (£285m)

Second new dredge arrives at the Moma Mine

This equipment forms part of the upgrade to Wet Concentrator Plant A. Progress remains on track.

SolGold (LON:SOLG) (£263m)

Multiple High-Grade Intervals at Tandayam-Ameríca

First 3 holes confirm high-grade resource. Fourth drill rig being added to expedite results.

Science (LON:SAG) (£244m)

Interim Results

H1 rev +6.5%, PBT +8% to £8.2m (exc. £24m gain on Ricardo (LON:RCDO)). Outlook: “well positioned” for FY.GREEN (Graham)
Some weakness in professional services is offset by strength in the two "Systems" businesses. Given the strength of the balance sheet and management's glowing M&A track record now, I think it's worth staying positive on this.

dotDigital (LON:DOTD) (£221m)

FY25 Trading Update

Revenue +6% w/ 94% recurring revenue. Average revenue per customer +8% to £1,923, and adjusted PBT expected to grow in line with expectations.
Forecasts at Cavendish reiterated “bar a small FX-related revenue adjustment” (£0.2-0.3m per annum). FY25 adjusted PBT forecast unchanged at £18.3m, FY26 £19.6m, FY27 £22.4m. Continues to assess further strategic M&A.
AMBER/GREEN (Graham) [no section below]
It’s been a while since I last looked at this one (November 2024); since then, its earnings estimates have wobbled a little but have now recovered and the stock is trading on a forward P/E of c. 14x, which I think is cheap by historical standards. It made a $35m acquisition last month, comprising a $20m upfront payment and a potential $15m earnout. Despite this, the company's cash balance remains strong at £36.2m (Dec 2024: £45.7m). Overall, I can find little for shareholders to complain about other than a share price that hasn’t been able to break out of its range of the past three years.
One slightly underwhelming feature of current performance, given the high-growth sector in which the company operates, is single-digit revenue growth. There are pockets of higher growth within the company, and it notes “strong double-digit percentages” internationally. Perhaps I should upgrade this already but I’ll conservatively leave it at AMBER/GREEN. The StockRank is improving but still only 57 for now.

Sovereign Metals (LON:SVML) (£211m)

Tariff Enviro Underscores Kasiya’s Significance

Graphite tariff highlights Kasiya’s potential to be world’s lowest-cost non-China producer ($241/t)

Aquila European Renewables (LON:AERS) (£205m)

Update on Sales Process

Revised offer from preferred bidder. Sales process paused, bidder no longer in exclusivity.
Ceres Power Holdings (LON:CWR) (£195m)Doosan Fuel Cell and Ceres joint announcementSP +45%
South Korean firm Doosan begins mass production of fuel cells using Ceres’ solid oxide tech. First sales expected in 2025, targeting AI and commercial applications, such as renewable microgrids.
This is the first time the company’s technology has been brought into mass production by one of its strategic partners.
AMBER/RED (Roland) [no section below]
Today’s news has met with a rapturous reception. Is this justified? It’s certainly positive that Ceres’ technology is in commercial production. But today’s update gives no clue as to the likely revenue impact and shouldn’t really be a surprise – the company confirmed in March that Doosan was on track for commercial product launch in 2025.
More broadly, I think it’s worth remembering that Ceres has lost money continuously for 20 years, since listing on the LSE in 2004.
Forecasts for 2025 prior to today showed revenue of £53m and a c.£20m annual loss, with similar in 2026. The company seems to have some good technology, but can it find a route to operating profitability? I don’t know, so I am going to maintain our previous cautious view.

Life Science Reit (LON:LABS) (£153m)

Strategic Review Update and Trading Update

Significant interest from a range of sources. NTA £232.1m/66.3p per share. Minor banking cov breach.

John Wood (LON:WG.) (£128m) (suspended)

Update on possible offer and PUSU extensions

Commercial alignment on headline terms of proposed refinancing in connection with possible offer.

PINK

EKF Diagnostics Holdings (LON:EKF) (£119m)

H1 2025 Trading Update

H1 in line. Revenues unch. at £25.2m. Adj. EBITDA +9% (cc). Full-year outlook in line.

STV (LON:STVG) (£89m)

FY Trading Update

SP -23%
Deterioration in commissioning and advertising markets: results materially below consensus.
Revised FY25 EPS estimates:
- Shore Capital: 9.1p (prev. 21.2p)
- Panmure Liberum: 11.7p (prev. 21.1p)
BLACK (AMBER/RED) (Roland)
This is a bad profit warning, with EPS estimates cut by c.50% due to a weaker outlook for both advertising and programme commissioning for the remainder of 2025. These issues highlight STV’s heavy dependence on the UK market and consequent exposure to the UK economy. With single-digit margins and rising leverage, I think it makes sense to take a cautious view here until some signs of stability emerge.

Kooth (LON:KOO) (£65m)

Half Year Trading and Operational Update

SP -9%
California in line with mgmt exps. Marketing spend to moderate in H2.
GBP/USD impacting EBITDA.
Net cash £15.1m (Dec 24: £21.8m) due to £1.5m buyback and investment in marketing and service delivery in California.
AMBER (Roland) [no section below]
Today’s update has received a poor reception. Reading the company’s commentary, I am inclined to attribute this to comments about the uncertain outlook for Medicaid spending, due to US federal cuts. Medicaid was previously seen as a potential source of growth to help reduce dependence on the California project, which is only a four-year contract. Another possible negative today is the unspecified FX impact on revenue and profits from the stronger dollar.
When I looked at Kooth’s results in April I took a moderately positive view, citing the modest valuation and good progress last year. Although the group’s cash balance remains impressive and provides a useful safety net, earnings are expected to be lower this year leaving the stock on a P/E of 19. To justify further growth from this valuation. I think Kooth may need a) a California renewal and b) further diversification of its revenue sources. While a positive outcome is certainly possible, I’m not sure how likely it is. For this reason, I’ve taken my view down one notch to neutral today.

Frenkel Topping (LON:FEN) (£61m)

Extension of PUSU deadline

Discussions with Harwood remain ongoing. Extension of deadline to 25th August 2025.

PINK

Kromek (LON:KMK) (£37m)

$5m received under Siemens Healthineers agreement

2nd payment after delivery of milestones by Kromek. $30m recovered so far, $7.5m remaining.

Everyman Media (LON:EMAN) (£37m)

Trading Update

Admissions +15%, revenue +21%. Net debt falls to £24m. Trading in line with expectations.
Unchanged forecasts from Canaccord Genuity: FY25 revenues £121.6m, adj. PBT minus £1.6m. FY26 revenues £135m, adj. PBT minus £0.4m.

RED (Graham) [no section below]
I’ve been negative on this one due to a lack of meaningful profits and concern that increased scale isn’t going to radically improve this picture. Today’s update shows growing top-line figures but it’s essential to bear in mind that they aren’t like-for-like, as the number of venues has increased from 41 to 48 over the past year. The two like-for-like figures provided are average ticket prices and average food and beverage spend. The company’s pace of expansion may slow down now with no further openings planned for 2025, and only two next year, so it will be interesting to see if the cash flow and profit performance can improve. They say “net debt repayment from operational cash flow expected in H2 2025”. According to forecasts, the company’s losses will reduce but it will remain loss-making through 2026. Nothing fundamental has changed after this in-line update and so I think that a negative stance remains justified. StockRanks identify this as a Value Trap.

Cordel (LON:CRDL) (£14m)

PTC Product Launch

Uses AI to detect/locate trackside assets with unprecedented automation and accuracy.

Capital Metals (LON:CMET) (£13m)

2nd Batch of Drill Assay Results

Potential for many multiples of existing resource to be achievable in the initial mining area.

OptiBiotix Health (LON:OPTI) (£12m)

Trading Update

Rev +102% to £557k. Cash £1.3m. Will see the effect of cost reductions in H2 2025.

RTC (LON:RTC) (£12m)

Interim Results

Profit from operations maintained at £1.3m. Optimistic about short, medium, long-term prospects.



Graham's Section

Science (LON:SAG)

Up 3% to 569p (£252m) - Interim Results - Graham - GREEN

I was a bit concerned about how long it would take, and how complicated it might be, for Science Group to generate a return on their investment in Ricardo (RCDO).

But as it happened, they made a very quick turn on this investment: £24m of pre-tax profit.

That boosts H1 PBT to £32.2m (H1 last year: £7.6m).

Their net funds have shot up from £26.4m to £70m, although this is before a £3.6m dividend and a £5.1m tax payment on Ricardo profits. So the current net funds figure is presumably around £61m.

Excluding their profits from Ricardo, Science Group’s overall H1 adjusted operating profit was £11.3m (H1 last year: £11m). “A strong performance in the Systems businesses offset the weaker market conditions within Professional Services.”

The high-performing “Systems” businesses are CMS2 (critical maritime systems and support) and Frontier Smart Technologies (a provider of radio chips and modules). FST was an AIM-listed company until it was acquired by Science back in 2019.

“Professional Services” have been unified under the Sagentia brand, and are under some pressure due to “the international political/economic volatility causing customers to defer, descope or cancel projects”. H1 revenue fell from £36.5m last year to £33.2m this year, while adj. operating profit fell from £8.8m to £7.9m, “a respectable performance in a period of exceptional volatility”.

Ricardo: Science invested £32.4m from Feb to May, and received £58m back from this investment in June after Ricardo received a takeover offer. I will be a bit more open-minded the next time Science starts investing in the stock market!

Borrowings: Science has £12m of term loans expiring in 2035, secured against freehold property. The rate on these has been fixed at 7.3%. There is also an undrawn £30m RCF that can be extended by another £10m. Given that Science Group has a large net funds position rather than net debt, this implies that it has a tremendous amount of liquidity available to it currently.

Indeed, they acknowledge that they have more cash than they need - I would say they have vastly more cash than they need. But given the success they’ve just had with Ricardo, perhaps there is no harm in keeping some dry powder? They say that they might not be able to find another suitable opportunity:

The Board recognises that the Group's cash resources exceed the Group's operating requirements, particularly for a business that is highly cash generative. Furthermore, with a limited UK-centred population of potential acquisitions and/or investments, there may or may not be suitable opportunities to deploy the capital in accordance with the Board's investment criteria. Accordingly, and taking into account the buy-back programme constraints, the Board shall keep under review the possibility of a return of capital to shareholders via a tender offer.

Estimates: Panmure Liberum have increased their PBT estimates by 4-5% for FY25 and FY26, thanks to higher interest receivable. Their new PBT estimates are £22.7m (FY25) and £23.5m (FY26), with corresponding EPS estimates of 37.7p and 39.2p.

Graham’s view

I went back to a fully positive stance on Science Group in June when news of the Ricardo takeover emerged.

I see little need to change that stance today, although the shares are more expensive now than they were then:

AD_4nXd0keVYzCDHc7ZJrDAyVbFwL0tu5B6Agsr9Ak2I0WXR-V2y5SRSJU14UtbmWKurZ3kDbmb6aCYFUAI06vJBmqMA7LUlcu227e37qmjJnzdgzWudK6SngELAj6782qGxQMdqbpAIsA?key=10BQaM91ZBjDIfnllPxBdA

Professional services/consulting is not a sector that I think should trade very richly, and it’s not a sector I’m inclined to be GREEN on very often, due to what I perceive as lower quality compared to other sectors. Most of Science’s operating profits are generated by this type of business.

However, the reasons I’m happy to be GREEN are:

  • Ricardo’s margins in Professional Services strike me as very good (23.9%), with management focused on maintaining these even in difficult conditions.

  • The cash balance covers about a quarter of the market cap, implying a high level of safety.

  • Adjusting for cash reduces the P/E multiple, e.g. it’s trading at about 14.5x next year’s EPS estimate, but this reduces to <11x on an enterprise value basis.

  • The Ricardo investment was remarkably successful, adding strong credibility to the company’s M&A track record.

  • Exec Chairman Martyn Ratcliffe is well-aligned to keep the success going, as the largest shareholder in the company.

  • Access to debt gives management additional flexibility, on top of the cash balance, to either return cash to shareholders or make new investments.

As a result, I’m staying GREEN on this one.


Roland's Section

STV (LON:STVG)

Down 23% to 147p (£69m) - FY25 Trading Update - Roland - BLACK (AMBER/RED)

As a long-suffering ITV shareholder, I’m familiar with the challenges being faced by traditional broadcasters as they navigate an ad slump and transition to a streaming-based world.

Unfortunately it’s ITV’s smaller, Scottish rival STV that appears to be suffering today. STV has issued a big profit warning that’s seen brokers cut their earnings forecasts for this year by around 50%. Commiserations to holders here.

AD_4nXd2_SI5TrFYfLnsCGmhqQUfNw5nCCZmc-DCbaxgs8ymAwwROT6ZQNLzWviXwFOvIWhBLQuYzqiJ7nyef6VJGPLNs_5RP4kDqHzsXsvA3FuM1mQAOOpmF7yITNGbVKM1qoEq1FbP?key=10BQaM91ZBjDIfnllPxBdA

Let’s take a look at what’s gone wrong.

Advertising slowdown

STV says H1 total advertising advertising revenue is in line with guidance, albeit 10% below the figure achieved last year. This largely relates to the boost provided by the men’s Euro 2024 football in June 2024.

However, “the recent further deterioration in the advertising market” means that the third quarter is now likely to be weaker than expected, with total ad revenue down by c.8% vs H2 24.

Audience outlook: as a result, revenue from the newly-formed audience division (broadcast & digital) is expected to be £90-95m this year, with an adjusted operating margin of 13-15%. From what I can see, previous estimates were for a margin of at least 15% and slightly higher revenue.

Studio slump

In my view, the narrative seems worse for the Studios division, which produces programmes for in-house use and for other broadcast and streaming platforms. Some well-known titles include Antiques Road Trip, Catchphrase and drama series Screw and Blue Lights.

STV Studios does serve clients such as Netflix, but its business is still mainly in the UK – and this seems to be a problem at the moment:

There has been significant commissioning market deterioration in late H1 and early H2 as the UK macroeconomic backdrop has worsened. This has impacted our unscripted labels with some projects in advanced development not being green-lit and some commissions being delayed to 2026.

The forward order book for Studios was £76m at the end of February, but has since fallen to £54m.

When last year’s results were published in March, STV said that the majority of the £76m order book was due for delivery in 2025.

The shrinkage since February tells me that the business is not winning new commissions to replace the programmes that are being delivered. This suggests to me that the current weakness could extend into 2026, as it will take time to rebuild the order backlog.

Studios outlook: the group’s programme-making division is now expected to generate revenue of £75-85m this year, at an adjusted operating margin of c.4% (FY24: 7.3%).

Outlook & Revised Estimates

Full credit to STV for being fairly transparent with its guidance today. But the company’s revised outlook is described as “materially below consensus” and represents a big setback versus 2024:

  • 2025 revenue to be £165-180m, with the range largely depending on Studios commissioning results (previously consensus £187m)

  • 2025 adjusted operating margin to be c.7% (previously 9.4% at Panmure Liberum)

Using the mid-point of the new revenue estimate suggests to me that adjusted operating profit could fall to £12.1m this year. Brokers Shore Capital and Panmure Liberum both have updated adjusted EBIT figures of just over £11m today, so are being even more conservative than me.

This new estimate is about 37% below previous estimates and would represent a drop of more than 50% relative to 2024 adjusted operating profit of £25.4m.

With thanks to three brokers who have provided updated estimates today, here are the latest EPS estimates for STV – they have all been cut by c.50%:

  • Shore Capital FY25E EPS: 9.1p (prev. 21.2p)

  • Panmure Liberum FY25E EPS: 11.7p (prev. 21.1p)

  • Progressive FY25E EPS: 11.4p (prev. 25.1p)

Roland’s view

This is a bad profit warning. The fall in STV’s margins continues a deteriorating trend that’s seen the group’s profitability collapse since the advertising market slump got underway in 2023. A partial respite last year has proved not to be sustainable:

AD_4nXcIWQFchLglNdBg91Y-GFUU1xwZvLYVqrVSjjVNe1GrqyAsCuMDrIRj6WbW2zJTS-wKg1xSLc72pB6vtGknRIbQB3paJeXC45lxkG3Ww5kbJSf2b5BH2Wf93PYB4mignviQjxoz?key=10BQaM91ZBjDIfnllPxBdA

A further short-term concern is that from what I can see, this revised outlook is likely to leave STV with a net debt/EBITDA leverage ratio of 2.0-2.5x at the end of 2025. While this is within the company’s covenant limit of 3.0x and may be manageable, it’s above my comfort level for a cyclical small cap with single-digit margins.

Although dividend forecasts are unchanged today at c.11.3p (implying a near-8% yield). I wouldn’t be surprised to see a dividend cut later this year if trading doesn’t improve.

Looking further ahead, this is a cyclical business and conditions may well improve as they have done in the past. STV is not in financial distress and remains profitable, with some useful programme franchises and a profitable broadcast/digital business that enjoys strong viewership share in Scotland.

My main concern is that STV may lack the scale and diversification in its Studios customer base that it needs to deliver sustainable and attractive margins.

Although the Studios unit might be attractive to other television production companies, its linkage with the broader STV business could make such a split more complicated. I wouldn’t bank on a rescue takeover bid, although it’s certainly a possibility.

The StockReport trend chart shows that today’s profit warning is the second cut to guidance in the last six months:

AD_4nXfdb1hEFQrcjVEHG53VH1ouvtxEKSzSjoCx5s3F-oa7lqVWrQ-77BH6zuXztv46oAnQ5tMK80j-o1CrPIMKFtHz1vCiqt7cUJ3eouqX1QY6tArqJR5DEd22KlUg_76_JibDtnPbjw?key=10BQaM91ZBjDIfnllPxBdA

Given STV’s near-total exposure to the UK economy and the tendency of companies to underperform after issuing profit warnings, I’m inclined to take a more cautious view after today’s update. AMBER/RED


Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

39 comments


Avatar for The Boon Fund

I am tempted by Everyman Media (LON:EMAN)

The bear case is well known. Perennially loss-making up until now. HUGE depreciation driving the big gap between Adjusted EBITDA and Statutory Operating Profit (c£20m gap at the FY Jan25 results on £16m of EBITDA!)

BUT.... EBITDA margin now looks like 14% for H1, maybe like c18-20% for H2. 

They seem to be able to increase ticket prices, F&B prices.

If they manage to increase next year again by 5-6%, and it all flows to adj EBITDA, that's a +33% adj EBITDA gain, and possibly I think Operating Profits of maybe a few million?

Still not amazing, but you can see the current £37m market cap making sense...

All back of the envelope but IMO its now looking possibly like the P&L could look sensible in 12 months time to the market cap.

3
Avatar for abtan

Everyman Media (LON:EMAN)

I'm a little late here, but as a cautious holder I thought I'd add a few comments:

---

  • "the number of venues has increased from 41 to 48 over the past year....
    ....no further openings planned for 2025
  • I hope it's okay for a small clarification.
    There were:
    • 41 venues at H1-2023,
    • 45 venues at H1-2024,
    • 48 venues at the end of H1-2025, 
    • 1 more opening is planned for 2025.
    • 2 openings are planned for 2026

  • The rate of expansion has really slowed down in the last couple of years, as it needed to; there were 6 new venues as recently as 2023 (38 ---> 44).

  • I prefer (and try) to calculate admission/available seat to see how the underlying business is doing given the expansionary nature of the business.

  • This is up +8% YOY% by my own estimates, which combines nicely with the +6% ticket/food/beverage spend per admission and + the 6% increase in seat #'s that drove the announced 20% top line growth.

71570828-efcc-409e-80ae-5b2fbb5f00c8.png

 

----

Boon

  • Spot on regarding the potential here. As I'm sure you'll recall I'm cautiously optimistic here.

  • Strip out the huge expansionary capex over the last few years and I believe that there is a highly cash generative business hiding somewhere underneath.
    With slower expansion I'm hoping that it comes out to say hello soon.

  • There are of course a few negatives. Three which spring to mind:
    • impaired venues over the last couple of years :(

    • higher NI charges this year :(

    • management do not engage with the PI community, which is a shame given their size and low share price. 
      I've struggled to find anything meaningful out there and it's unfortunate that they don't even do the odd interview following result announcements.

4
Avatar for The Boon Fund

Thanks abtan! Now gone onto my to-do list to have another look again. 

Definitely falls into my favourite category.... an unloved share by investors generally, but one where the situation has changed (or is changing soon) since that label was given.

2
Avatar for The Boon Fund

Things are getting very bad for companies in the UK…. good for Begbies Traynor (LON:BEG) though.

Begbies releases a quarterly “Red Flag” report on the state of corporate distress in the UK.

I’ve now compiled it in an easy summary, showing the 3m and 12m growth for Significant Distress and Critical (worse) Distress.

dd21c90d-1b02-43c4-9a72-03234bda3ee6.png

You can see over the past year to Q1-25 (Mar25), growth has been a bit erratic. However, that still drove a 11% organic growth in the Business Recovery side of the business.

But look at the Q2 numbers…! QoQ growth, and YoY growth, all quite healthy percentages. And higher absolute numbers than any of the preceding 4Qs (in fact, highest ever numbers since I started tracking from Q4-2022).

Think it is setting it up for a solid growth year for Begbies, at this rate.

(I hold in the Boon Fund)

6
Avatar for FREng

Cordel (LON:CRDL) seems to have some excellent technology. I wonder when (if) it will lead to strong profits and a stronger SP. 

3
Avatar for snowdrop

There is a new Edison video with their product guy. It/he was so dull I stopped watching. Also how many Class 1 US railroads are there? The Economist is talking consolidation in the US for them. I'm less convinced than I was, so I sold out at a loss. So you are probably on to something!

1
Avatar for carmensfella

Very impressive that RTC ( LON:RTC) manage to get their interim results out within 28 days. There are very few companies that can beat that..

They read well and management sound confident for the rest of the year and actually say 'optimistic about short, medium and long term prospects'

When the rail 'project' and upgrades work as opposed to just maintenance work that they currently undertake gets back to normal the company will be significantly ahead on profits. Good to see the confidence and improvement in dividend by 10% event though they have spent heavily buying back shares.

Net cash inflow of £3.3m bodes well and at some point there may be a special dividend with the finals.

Fully diluted eps at 7.07p (2024 6.01p)

There are no forecasts or research out there so it takes a long time for the company to be appreciated by investors. I did request action on this at the Agm but I was the only one there but it was promised so I will hold them to it. With results out I now expect those to follow within a month.

I do think that for the full year to December we are now likely to see eps close to 17p and if this does not get to a rating much higher than just six times earnings then I expect a bigger player to come in and snaffle the business.

The share price really should be reaching new highs as the dividend at 7% is higher than the earnings multiple which is extremely rare for a company increasing earnings rather than distressed which RTC certainly is not..

12
Avatar for Patrickmylnetrade

Thanks David, I’m always curious as to what u have in your portfolio! :) are you willing to share any others (hadn’t heard of RTC)


0
Avatar for carmensfella

I do not really get involved in sharing my portfolio as I have far too many holdings to do that. Naturally you should research any for yourself anyway but I can share that my largest holdings are nearly always in ones that I have built my position over a number of years and have probably grown considerably as I tend to sit tight. Games Workshop GAW is one of my largest and Renold RNO is another but that is about to leave the market in a takeover. Time Finance TIME, Tandem Group TND, Journeo JNEO and Spectra Systems SPSY make up my top seven.

14
Avatar for Patrickmylnetrade

Thanks David appreciate the disclosure,   DYOR is a stocko pillar of course

0
Avatar for piemagico

The commentary on STV (LON:STVG) reflects on the poor UK macro environment, but it's in contrast with an upbeat update (results?) from ITV (LON:ITV) last week. Do any analysts of these companies have views on whether there is something different about ITV that justifies its high StockRank? 

5
Avatar for Roland Head

Morning piemagico,

The two big differences for me between ITV (LON:ITV) and STV (LON:STVG) are their size and the international exposure of their Studios businesses.

ITV group revenues are c.18x greater than those of STV.

In 2024, ITV Studios (the programme-making business generated more than half the division's c.£2bn revenue overseas or through global partnerships. This includes a significant US business.

In contrast, today's update from STV admits that its international expansion is still at an early stage.

I think ITV's greater scale and much larger audiences are significant advantages,  strengthened further by the international customer base of its Studios business.

Disclosure: I hold ITV

Roland

23
Avatar for gwigglesdarton

Ocean Wilsons Holdings (LON:OCN) - This looks like an interesting example of the dangers of being at the mercy of much larger shareholders.  About £14.50 in the market yesterday and a recommended combination this morning which based on the current Hansa share prices (two share types) seems to be valuing them at about £12.30 in shares. A combination might make sense, but this seems like the board of Ocean Wilsons have agreed to it at a big discount.

8
Avatar for fred9566

I hold Ocean Wilsons Holdings (LON:OCN) shares and understanding what is actually happening is proving difficult (other than OCN shares dropping by 12%this morning) .It would be great if Graham could apply his analytical skills to decipher what is going on . 

6
Avatar for gwigglesdarton

I agree, not the clearest situation or RNS and more than happy to have someone check my own figures. My interpretation is that for each Ocean Wilsons Holdings (LON:OCN) share you would get 1.4925 Hansa 'units' with each unit being one voting Hansa Investment (LON:HAN) share and two non-voting Hansa Investment (LON:HANA) shares. The current mid price on these is about 282p for the voting shares and 268p for the non-voting ones. That means 282+2x268p or 818p per unit which means each Ocean Wilsons being exchanged for 1.4925x818p or about £12.21 in Hansa shares at the current value, which seems very miserly considering the market price of late.

8
Avatar for Nurzel

There is currently a merger arbitrage opportunity where you can sell Ocean Wilsons Holdings (LON:OCN) and buy Hansa Investment (LON:HANA) and make an almost risk free profit, given that the merger is very likely to go through due to high level of irrevocables. This is the reason behind the drop in Ocean Wilsons Holdings (LON:OCN). 

I hold both shares and once the merger has gone through it is very likely that the NAV discount on Hansa Investment (LON:HANA) will narrow substantially from currently over 30% to something more in line with other investment trusts of 10-20%, given (i) larger NAV of £900m and thus more liquid shares, (ii) focus on developed markets post Brazil port disposal, (iii) reduced mgmt fee, (iv) abolishment of performance fee payment to the manager, (v) high net cash of ~£300m from the sale of Wilson Sons. 

If it plays out like that there is substantial SP upside to both Ocean Wilsons Holdings (LON:OCN) and Hansa Investment (LON:HANA) of over 20%, but the upside on Hansa Investment (LON:HAN) is bigger than Ocean Wilsons Holdings (LON:OCN) based on current SPs and that's why Hansa Investment (LON:HANA) is going up this morning and Ocean Wilsons Holdings (LON:OCN) down. 

If you are an investor and not a trader I would stay put and wait until the merger goes through and NAV discount narrows / SP goes up, which should be the case in Q4 this year.  Alternatively, you can sell OCN and buy HANA to play the merger arbitrage. I have added to my Hansa Investment (LON:HANA) position this morning and have not sold any of my OCN shares.

21
Avatar for dscollard

Ceres Power Holdings (LON:CWR) not on the list but a very significant catalyst from this am. here is my pre market take  - posted on X  here  

Up +33% intraday on the news 

eae29765-4843-4027-9070-ac1f888ffe11.png

6875200f-8405-47b4-9aa6-df8993f49ce1.png

19
Avatar for bsharman

Not a great start to the week for STV (LON:STVG) - here is an AI summary: 

STV Group plc has issued a trading update for the full year 2025, revealing that its expectations for full year revenue and adjusted operating profit are materially below consensus due to a deterioration in both the commissioning and advertising markets.

Key Financials and Outlook

  • Full Year 2025 Group Revenue: Expected to be in the range of £165m to £180m, with approximately £10m of this range influenced by updated Studios guidance. In 2024, STV reported revenue of £188.0 million.
  • Adjusted Operating Margin: Forecast at around 7% for the full year. For comparison, in 2024, the adjusted operating margin was 11.0%.
  • Cost Savings: An additional £750k in cost savings has been identified for FY25, bringing the total target for the year to £2.5m. Further savings are anticipated for FY26.
  • Net Debt: Group core net debt stood at £30m at the end of June 2025 (compared to £29m at 31 December 2024). Production financing was reduced from £10m to £5m in H1 due to successful program deliveries.

Audience Division Performance

The Audience division has seen its full year 2025 revenue and adjusted operating margin revised to a range of £90m to £95m and 13% to 15% respectively.

  • H1 Total Advertising Revenue (TAR): In line with previous guidance, though Q2 was impacted by strong comparators due to the men's Euro 2024 in the previous year.
  • Q3 2025 TAR Outlook: Expected to be down approximately 8%. This includes July being down around 20% (due to the Euro 2024 comparator) with August and September anticipated to be broadly flat.
  • Comparison to 2023: H1 TAR is up 3% compared to 2023, while the Q3 outlook is down 4% compared to 2023.
  • Advertising Revenue Breakdown (YTD and Q3 outlook):

2025Q1Q2H1Q3 Outlook
Total Advertising Revenue (TAR)-3%-17%-10%c. -8%
National linear-7%-25%-16%c. -12%
Regional linear+2%+1%+2%c. -11%
VOD+8%+2%+5%c. +10%

Export to Sheets

STV Studios Update

The STV Studios division has been significantly impacted by a worsening UK macroeconomic backdrop and deterioration in the commissioning market, particularly for unscripted labels in late H1 and early H2.

  • Commissioning: Some unscripted projects have been delayed or not green-lit, despite 13 unscripted commissions being secured in Q2. Scripted labels, however, remain strong with ongoing projects for Netflix, Apple, Sky, and the BBC, with no change to their financial expectations for the year.
  • Full Year Outlook: Revised to revenue in a range from £75m to £85m at an adjusted operating margin of approximately 4%, as lower activity volumes affect fixed overhead recovery.
  • Forward Order Book: Reduced to £54m, down from £66m at the end of April, reflecting the slowdown in new commissions and revenue recognition from programs already in production.

Strategic Progress

STV Group is continuing to implement its "FastFwd to 2030" strategy. Progress is being made on establishing an audio business with plans for a new radio station, and the creation of a single Audience business aims to streamline operations.

Rufus Radcliffe, CEO of STV Group plc, acknowledged the challenging macroeconomic environment but emphasized the company's proactive response through targeted growth initiatives and efficiency drives. He reiterated confidence in the long-term growth potential despite short-term challenges.

STV Group plc plans to provide a further update on its full year outlook and strategic progress during its interim results announcement in September 2025.

10
Avatar for imranawan1980

Did you put the trading statement into an AI program to generate the summary. 

1
Avatar for bsharman

yes 

2
Avatar for The Phoenix

When you pasted the trading statement into AI what prompts did you then use ?

Thanks

Andy

0
Avatar for bsharman

I didn't - I just copied and pasted the statement into Gemini. 

1
Avatar for TStubbs

I'm in the industry, nothing much is being commissioned and there is still a backlog on previous commissions being aired. Stuff being commissioned is being made on zero profit  -commissioners are taking full advantage of production companies trying to keep their lights on. I wouldn't touch this industry at the moment, and can't see things changing any time soon sadly.

29
Avatar for bsharman

the ITV (LON:ITV) statement from a few days ago was fairly positive on studios though? 

5
Avatar for Spider1234

Look at all that cash! Science (LON:SAG)

9
Avatar for Mark Carter

CWK Correction: Revs up 9.7%, not 7.9%.

0
Avatar for Roland Head

Morning Mark,

I've used the LFL figure which is 7.9%. I think total revenue growth (inc acquisitions) was 9.7%.

Roland

5
Avatar for Mark Carter

Ah, OK. Fair enough.

1
Avatar for snowdrop

I have to Fess up, What does the abbreviation TTM mean?

1
Avatar for Peter T

redundant as answered by Roland

1
Avatar for Roland Head

Trailing 12 months. In other words, the last two six-month accounting periods, either H1/H2 or H2/H1.

Roland

9
Avatar for snowdrop

Thanks gents

3
Avatar for Christine H

Trailing twelve months 

2
Avatar for 10Bagger

Trailing 12 months

2
Avatar for eggbaconandbubble

'9' Handle???  I've Googled it but none the wiser!

1
Avatar for stehuk

'9' Handle:  The FTSE 100 index is over 9000.

1
Avatar for Graham Neary

I added the meaning to the article - apologies!

7
Avatar for eggbaconandbubble

Forgiven! ;-) You have to allow for idiots like me!

11
Avatar for Silver Moon

It was too early in the day for me to get a handle on it.

18
Get the free newsletter